← Back to catalogue

Cards Q.S. Hcg or Concise Performance Plus Hcg

FDA 510(k)

Class II (US FDA 510(k))

510(k) K954273

by Quidel Corp.

Identifiers

510(k) Number
K954273 FDA 510(k)
FDA Product Code
JHI FDA 510(k)

Classification

Device Class
Class II FDA 510(k)
Legislation / Framework
21 CFR Part 862.1155 FDA 510(k)
Regulation Number
862.1155 FDA 510(k)
Advisory Committee
Clinical Chemistry FDA 510(k)
FDA Decision
SESE Substantially Equivalent FDA 510(k)

The Cards Q.S. Hcg or Concise Performance Plus Hcg is a visual human chorionic gonadotropin (hCG) test system. It is designed for the qualitative detection of hCG, a placental hormone, in urine to aid in the early detection of pregnancy.

This device is intended for prescription use and is regulated under 21 CFR 862.1155. It has received FDA 510(k) clearance as a substantially equivalent clinical chemistry device.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: Cards Q.s. Hcg Serum/Urine;Concise Performance Plus Hcg-combo (K973858 ..., PDF nje5361 - Food and Drug Administration, Cards Q.s. Hcg-urine; and Concise Performance Plus Hcg-urine

Authorization Coverage (1 country)

Regulatory Authorizations

United States Active

FDA_510K

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Quidel Corp.

Sources (1)

  • FDA 510(k) K954273 24 fields · synced Sep 21, 2026